People · Operator
Named in public records as an officer, director or promoter · active 2013–2020 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vir Biotechnology, Inc. | — | Biotechnology | Series D+ | $348.4M | $1.3B | 2018 |
| Omni Bio Pharmaceutical, Inc. | — | Pharmaceuticals | Series B | $29.8M | $52.4M | 2013 |
Michael Kamarck at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Kamarck on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Nelsen | 1 | 22 |
| Kristina Burow | 1 | 16 |
| Robert More | 1 | 7 |
| Vicki Sato | 1 | 6 |
| George Scangos | 1 | 4 |
| BRIAN KLEMSZ | 1 | 4 |
| Thomas Daniel | 1 | 4 |
| Saira Ramasastry | 1 | 4 |
| Robert Perez | 1 | 3 |
| Dipchand Nishar | 1 | 3 |
| Jay Parrish | 1 | 2 |
| JEFFREY SPERBER | 1 | 2 |
| Vicki Barone | 1 | 2 |
| Michael Iseman | 1 | 2 |
| Philip Sharp | 1 | 2 |
| JAMES CRAPO | 1 | 2 |
| ROBERT OGDEN | 1 | 2 |
| Steven Bathgate | 1 | 2 |
| Michael Wort | 1 | 1 |
| Albert Kramer | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.